Research: News & Photos

print this page | close window

Christopher A. Walsh Laboratory 

The Scientist - September 14th, 1998

Notebook: Good Thinking

By multiple authors

From a research point of view, the problem with most genetic causes of mental retardation is that a number of genes are involved, affecting several organs, and therefore providing little new insight into how the brain works. But recent discoveries concerning mutations that cause nonsyndromic X-linked mental retardation (MRX), show promise of helping to explain normal cognitive functions. MRX affects 1 in 600 males, whose brain development generally seems otherwise normal, and who exhibit few or no other signs of retardation. However, MRX syndromes are genetically diverse, comprising more than 60 pedigrees. Genes for several pedigrees have been located on the X chromosome, the latest identified by a multi-institution research group that found a defect in the PAK3 (p21-activated kinase) gene for the MRX30 pedigree (K.M. Allen et al., Nature Genetics, 20:25-30, Sept. 1998). "Because the protein is brain-specific and clearly has a brain phenotype, we can isolate its functions," explains lead author Kristina M. Allen, a Harvard Medical School researcher at Beth Israel Deaconess Medical Center. PAK3 appears to be involved in both signal transduction and in regulating neuronal cell shape. In particular, it may affect axonal and dendritic development. Although the group has been working with cell lines, the amino acid sequence of PAK proteins is highly conserved. "Our next step is to look at the effects [of PAK3] on neuronal growth and development in cells," Allen says, after which the mutation can be introduced into mice, to see what role it plays in relation to other known mental retardation genes.


2001-2005 All Rights Reserved - Dr. Christopher A. Walsh Laboratory